The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Open accessAbstract
Aptamers are short, single-stranded oligonucleotides that bind to specific target molecules. The shape-forming feature of single-stranded oligonucleotides provides high affinity and excellent specificity toward targets. Hence, aptamers can be used as analogs of antibodies. In December 2004, the US Food and Drug Administration approved the first aptamer-based therapeutic, pegaptanib (Macugen), targeting vascular endothelial growth factor, for the treatment of age-related macular degeneration. Since then, however, no aptamer medication for public health has appeared. During these relatively silent years, many trials and improvements of aptamer therapeutics have been performed, opening multiple novel directions for the therapeutic application of aptamers. This review summarizes the basic characteristics of aptamers and the chemical modifications available for aptamer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Overall structure of known aptamer–protein complexes with electrostatic surface potential [5]. The RNA aptamer is represented by a yellow ball-and-stick model. (A) Aptamer–thrombin complex at 1.8 Å resolution [13]. (B) Aptamer–nuclear factor-κB complex at 2.45 Å resolution [11]. (C) Aptamer–MS2 coat protein complex at 2.8 Å resolution [12]. (D) Aptamer–Fc region of human IgG1 (hFc1) complex at 2.15 Å resolution [16]. Blue areas: positively charged; red areas: negatively charged.](/paper-figures/326433949fe441b395fc323372023226/aptamers-a-review-of-their-chemical-properties-and-modifications-for-therapeutic-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the increasing recognition of the vital role played by RNA in transferring cellular information and regulating genes, targeting RNAs has become an exciting opportunity to therapeutically modulate cellular processes linked to previously “undruggable” protein targets.550–552”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [552]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,421
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 2×
“reported that sgRNA has loop regions outside of Cas9, and a natural RNA aptamer could be integrated [92].”
BackgroundTherapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,629
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,539
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Ruckman, J., Green, L. S., Beeson, J., Waugh, S. M., Gillette, W. L., Henninger, D. D., Claesson, L., & Janjić, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 759
Cited by
Sorted by citations
Items 201–300 of 305
Bruce‐Tagoe, T. A., Harnish, M. T., Soleimani, S., Ullah, N., Shen, T., & Danquah, M. K. (2024) · Biotechnology Progress · doi:10.1002/btpr.3475 · Cited by 5
The Use of Thermal Dissociation for Selection of DNA Aptamers
Lapa, S. A., Shershov, V. E., Krasnov, G. S., Volkova, O. S., Kuznetsova, V. E., Radko, S. P., Заседателев, А. С., & Chudinov, A. V. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s106816202004010x · Cited by 5
Abeykoon, S. W., Dikella, W. N., Santos-Cancel, M., Lazenby, R. A., & White, R. J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c01604 · Cited by 4
RNA therapeutics for metabolic disorders
Vu, T.-D., Lin, S., Wu, C., & Chu, D. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.014 · Cited by 4
In silico selection of aptamers against SARS-CoV-2
Shukri, A. M. A., Wang, S. M., Feng, C., Chia, S. L., Nawi, S. F. A. M., & Citartan, M. (2024) · The Analyst · doi:10.1039/d4an00812j · Cited by 4
Novel paper sensor with modified aptamer for accurate detection of clinical cardiac troponin I
Xie, Q., Wu, D., Chen, Q., Liang, H., Wang, L., & Qiu, X. (2025) · Nanoscale · doi:10.1039/d5nr00073d · Cited by 4
Selection and Application of Aptamer Affinity for Protein Purification
Santos, A. P. D. J., Oliveira‐Giacomelli, Á., de Sá, V. K., do Nascimento, I. C., Molina, E. D. S., & Ulrich, H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2176-9_13 · Cited by 4
Potential use of SMART implants in traumatology and orthopedics: a review
Dontsova, O. A., Nazarenko, A. G., Krupatkin, A. I., Кулешов, А. А., Kleimyonova, E. B., Vetrile, M. S., Tairov, G. N., Zavyalova, E. G., Agina, E. V., Kydralieva, K. A., et al. (2025) · N N Priorov Journal of Traumatology and Orthopedics · doi:10.17816/vto678583 · Cited by 3
Chatterjee, D., & Tiwari, I. (2026) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2026.101816 · Cited by 3
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides
Rodrigues, D. A., Pires, G. S., Roy, U., Conway, E., & Pinheiro, P. D. S. M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118688 · Cited by 3
Illuminating the Invisible: Translational Molecular Imaging in Cardiovascular Medicine
Ma, Y., Sun, N., Fang, Y., Wang, Y., & Cao, F. (2026) · Circulation Research · doi:10.1161/circresaha.125.327199 · Cited by 3
Morrissey, K. L., DeWitt, D., Shah, N., Fall, W. B., Shah, H., & McGown, L. B. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03328-1 · Cited by 3
Mahmoud, R., Kalivarathan, J., Castillo, A. J., Wang, S., Fuglestad, B., Kanak, M. A., & Dhakal, S. (2023) · Biotechnology Journal · doi:10.1002/biot.202300374 · Cited by 3
RNA therapeutics history and future perspectives
Duong, H., Hoang, M.-C., Nguyen, T.-H., Ngo, V.-L., & Le, V.-T. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.01.004 · Cited by 3
Joshi, A., Kaushik, A., Taneja, N. K., Chauhan, K., Kumar, A., & Sharma, T. K. (2024) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2024.100555 · Cited by 3
DNA-Aptamer-Based qPCR Using Light-Up Dyes for the Detection of Nucleic Acids
Goyal, S., Singh, P., Sengupta, S., Muthukrishnan, A.-B., & Jayaraman, G. (2023) · ACS Omega · doi:10.1021/acsomega.3c07599 · Cited by 3
Aptamer-Based Switching System for Communication of Non-Interacting Proteins
Kim, Y., Nam, D., Lee, E. S., Kim, S., Cha, B. S., & Park, K. S. (2024) · Biosensors · doi:10.3390/bios14010047 · Cited by 3
Multiple Myeloma: Therapeutic Delivery of Antibodies and Aptamers
Pujol-Navarro, N., Qaraghuli, M. M. A., Kubiak-Ossowska, K., Alsaadi, M., Horne, G. A., Soutar, R. L., Paspali, E., Ferro, V. A., Williams, M. T. S., & Mulheran, P. A. (2021) · Therapeutic Delivery · doi:10.4155/tde-2021-0041 · Cited by 3
Kaneko, A., Watari, M., Mizunuma, M., Saito, H., Furukawa, K., & Chuman, Y. (2020) · Catalysts · doi:10.3390/catal10101153 · Cited by 3
Shi, K., Zhang, J., Yuan, R., & Xiang, Y. (2025) · The Analyst · doi:10.1039/d5an00458f · Cited by 2
Moghadam, S. M. M., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2527865 · Cited by 3
Baccaro, A., Cardoso, P., Píccoli, R. H., Bufalo, T. C. E., Martins, R. C., Vilela, T., Alves, A. C., Pereira, L., & Felix, F. S. (2025) · Brazilian Journal of Analytical Chemistry · doi:10.30744/brjac.2179-3425.rv-189-2024 · Cited by 2
Engineered RNA Devices for In Vivo Targeted Therapeutics via Advanced Delivery Systems
Luo, W., Liu, X., Han, Y., Duan, Y., Yu, C., Kong, N., & Xie, T. (2025) · Aggregate · doi:10.1002/agt2.70191 · Cited by 2
Qureshi, J. A., Abdollahi, G., & Tabib‐Azar, M. (2025) · IEEE Nanotechnology Materials and Devices Conference (NMDC) · doi:10.1109/nmdc64551.2025.11234005 · Cited by 2
Aptasensors in colorectal Cancer: Emerging tools for precision diagnostics
Abuhassan, Q., Atoom, A. M., Roopashree, R., Kanwar, J. B., Sudhakar, T., Sharma, V., Chauhan, A. S., & Ruziyev, O. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120751 · Cited by 2
Fitzgerald, N. J., Huang, W., & Clark, K. D. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345154 · Cited by 2
Uğurlu, Ö., Gök, O., Ülker, G., Soytürk, H., Özyurt, C., & Evran, S. (2026) · Discover Molecules · doi:10.1007/s44345-025-00044-6 · Cited by 2
Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies
Best, N., Karabiyik, G., Geerling, G., Zwingelberg, S. B., Lang, G., & Humeník, M. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505182 · Cited by 2
Bora, N. R., Kumar, R., Kumar, S., & Kumar, S. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108669 · Cited by 2
Oligonucleotide Complexes in Bioorganometallic Chemistry
Lönnberg, T., Hande, M., & Ukale, D. U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820206-7.00030-5 · Cited by 2
Whole Cell Yeast-Based Biosensors
Shepherd, H. A. M., Bondarenko, E.-M. A., Jennings, K. M., Miller, R. A., & Goodson, H. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-89680-5_4 · Cited by 2
Generation of DNA-aptamers targeting galectin-7 for the identification of cholesteatoma residue
Liu, S., Takemasa, E., Suzuki, Y., Javkhlant, A., Takagi, T., Yamada, H., Abe, Y., Hato, N., & Mogi, M. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.08.002 · Cited by 2
Mesyl Phosphoramidate Oligonucleotides: A New Promising Type of Antisense Agents
Stetsenko, D. A. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_19 · Cited by 2
Targeting strategies using gold nanoparticles for efficient drug delivery
Wheate, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19061-2.00016-x · Cited by 2
Breaking Barriers: Nucleic Acid Aptamers in Gastrointestinal (GI) Cancers Therapy
Uinarni, H., Oghenemaro, E. F., Menon, S. V., Hjazi, A. M., Ibrahim, F. M., Kaur, M., Zafarjonovna, A. Z., Deorari, M., Jabir, M. S., & Zwamel, A. H. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01367-w · Cited by 2
Zhu, Z., Yang, J., Tong, P., Niu, C., Ahmad, N., Zhang, L., Yuan, H., & Song, Y. (2024) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2024.106922 · Cited by 2
Study on the detection of antibiotics in food based on enzyme - free labelless aptamer sensor
Kakimova, Z., Жарыкбасова, К. С., Какимов, А. К., Мирашева, Г. О., Толеубекова, С. С., Zharykbasov, Y., Tulkebayeva, G., Muratbayev, А., & Utegenova, A. (2022) · Food Science and Technology · doi:10.1590/fst.70421 · Cited by 2
Current status in clinical advancement of RNA therapeutics – Correspondence
Chatterjee, S., Bhattacharya, M., Agoramoorthy, G., & Chakraborty, C. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106996 · Cited by 2
RNA therapeutics for β-thalassemia
Duong, H., Nguyen, T.-H., Hoang, M.-C., Ngo, V.-L., & Le, V.-T. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.12.006 · Cited by 2
A novel platform for metabolomics using barcoded structure-switching aptamersPreprint
Tan, J. H., Mercado, M. P., & Fraser, A. G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.09.544402 · Cited by 2
Paradis, N. J., Clark, A. K., Dutta, A., Gogoj, H., Vaden, T. D., & Wu, C. F. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124407 · Cited by 1
Antithrombotic but not anticoagulant activity of the thrombin‐binding RNA aptamer Apta‐1
Jedlina-Panasiuk, L., Paramel, G. V., Soboleva, S., Olin, O. C., Haug, M., Fransén, K., Lindstam, M., Brewińska‐Olchowik, M., Piwocka, K., & Grenegård, M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17382 · Cited by 1
Exploring Molecular Binding: A Fluorescence Anisotropy Lab for Undergraduates
Forder, M., Rivera, M., Chen, Y., Phénix, J., Shomali, T., Munter, L. M., & McKeague, M. (2025) · Journal of Chemical Education · doi:10.1021/acs.jchemed.4c01023 · Cited by 1
Aptamer-based Biosensors for Monitoring Food Quality and Safety
Bruce‐Tagoe, T. A., Jeevanandam, J., Pan, S., & Danquah, M. K. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674787-00091 · Cited by 1
Aptamers: A Novel Class of Targeted Therapeutics
Yadav, L., Kumar, S., Srivastava, S., & Golmei, P. (2025) · Springer eBooks · doi:10.1007/978-981-96-8387-1_3 · Cited by 1
Ng, S. S., Sandall, I. C., Chiu, H., & Doong, R. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118439 · Cited by 1
Sahithi, D., Rizwan, A., Gupta, G., Hani, U., Haider, N., Goh, K. W., & Kesharwani, P. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115843 · Cited by 1
Aptamers targeting immune checkpoints for tumor immunotherapy: a comprehensive review
Gedla, M. K., Kotla, R. S. P., Kumar, R., Kamesh, V., Joshua, S., Kamalakannan, D., & Ramasamy, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1762902 · Cited by 1
Facile synthesis of tunable zinc–adenine frameworks for aptamer-based biological applications
Nguyen, C. M., Trịnh, Q. T., Nguyen, N.-T., & Ta, H. T. (2026) · Materials Chemistry Frontiers · doi:10.1039/d6qm00114a · Cited by 1
Surface-Tailored Nanocarrier Drug Delivery Systems: Emerging Tools for HIV Management
Gupta, K., Mukherjee, A., & Kumar, S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02543-3 · Cited by 1
Leandro, L. D., Colasante, M., Catanesi, M., Giansanti, F., Cimini, A., d’Angelo, M., Castelli, V., Savino, R., & Ippoliti, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188231 · Cited by 1
Nisar, J., Sarwar, M., Shah, S., Yasmin, S., Farooq, H., Moin, H., & Mustafa, I. (2025) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_202_25 · Cited by 1
Recent advances in the analysis of the evolutionary RNA based therapeutics; a review
Khalil, H. A., El-Sayed, N. W., Elmoslhy, R. M., & El-Yazbi, A. F. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150466 · Cited by 1
Gita, L. I., Jang, S. J., & Kim, T. H. (2026) · Sensors · doi:10.3390/s26061937 · Cited by 1
Mesyl Phosphoramidate Oligonucleotides: A New Promising Type of Antisense Agents
Stetsenko, D. A. (2023) · Springer eBooks · doi:10.1007/978-981-16-1313-5_19-1 · Cited by 1
Liang, X., He, C., & Shen, H. (2024) · Talanta · doi:10.1016/j.talanta.2024.125672 · Cited by 1
Origin of ribonucleotide recognition motifs through ligand mimicry at early earth
Mozumdar, D., & Roy, R. N. (2024) · RNA Biology · doi:10.1080/15476286.2024.2423149 · Cited by 1
Apta-Nanobiosensors in Precision Agriculture: Methods and Applications
Gogoi, R., Daimari, F. S., Sarma, H. H., Rath, A., Sharma, M. R., Anshu, Barooah, M., & Bora, S. S. (2025) · Sustainability Sciences in Asia and Africa · doi:10.1007/978-981-96-8335-2_6 · Cited by 1
Challenges and Limitations in Aptamer-Based Cancer Diagnosis and Therapy
Nangare, S., Pawara, D. L., & Tade, R. S. (2025) · Springer eBooks · doi:10.1007/978-981-96-8387-1_12 · Cited by 1
Kukushkin, V. I., Kristavchuk, O. V., Zhdanov, G. A., Keshek, A. K., Gambaryan, A. S., Andreev, Y. V., Nechaev, A. N., & Zavyalova, E. G. (2023) · Известия Российской академии наук Серия физическая · doi:10.31857/s0367676522700375 · Cited by 1
Moulick, U. G., & Bhattacharjee, S. (2020) · Bioanalysis · doi:10.4155/bio-2020-0099 · Cited by 1
Dynamic and Mechanical Applications of DNA Nanostructures in Biophysics
Shahhosseini, M., Kucinic, A., Beshay, P. E., Pfeifer, W. G., & Castro, C. E. (2022) · Wiley eBooks · doi:10.1002/9781119682561.ch5 · Cited by 1
Ultrahigh-throughput discovery of modified aptamers as specific and potent enzyme inhibitorsPreprint
Husser, C., Hoetzel, J., Cubí, R., Lebars, I., Kraus, L., Primo, C. D., Baudrey, S., Proschak, E., Kieffer, B., Suess, B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.16.608213 · Cited by 1
Chumakov, D. S., Kichkailo, A. S., Сергеевна, З. Г., Буров, А. М., & Khlebtsov, N. G. (2022) · Computational Biophysics and Nanobiophotonics · doi:10.1117/12.2626120
Introduction to a review series on RNA therapeutics in hematology
Gotlib, J. R. (2023) · Blood · doi:10.1182/blood.2023020910
Cyanotoxins availability and detection methods in wastewater treatment plants: A review
Manjitha, K. G. L., & Sewwandi, B. G. N. (2023) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2023.106886
RNA therapeutics in hematology
Mandal, P. K. (2024) · Journal of Hematology and Allied Sciences · doi:10.25259/jhas_5_2024
Komova, N. S., Serebrennikova, K. V., Berlina, A. N., Zherdev, A. V., & Dzantiev, B. B. (2024) · Journal of Analytical Chemistry · doi:10.1134/s1061934824040099
Bultas, J. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.043
Complement and Complement-Mediated Toxicity
Twardy, S. M., Frazer‐Abel, A. A., & McCullough, R. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00145-5
Current and Future of Complement Therapeutics and their Impact on the Clinical Immunology Laboratory
Dixon, B. P., Purohit, S., & Frazer‐Abel, A. A. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch12
Komova, N. S., Serebrennikova, K. V., Berlina, A. N., Zherdev, A. V., & Dzantiev, B. B. (2024) · Journal of Analytical Chemistry · doi:10.31857/s0044450224050116
Mustafa, I., Iqbal, M. K., Khan, B., Khan, H., Shahab, S., Shah, U. D., Kiyani, M. M., Haq, B. U., Bashir, S., & Nisar, J. (2025) · Research Square · doi:10.21203/rs.3.rs-6318491/v1
Seele, P. P., van der Walt, H., Sibuyi, N. R. S., & Maserumule, C. (2025) · Wiley eBooks · doi:10.1002/9781394287697.ch9
Nucleic Acid-Based Systems for Regenerative Medicine
Martín, L., & Grzela, D. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-87744-5_8
Avacincaptad pegol, the second approved aptamer medicine – A mini review
Bege, M., Kattoub, R. G., & Borbás, A. (2025) · De Remediis · doi:10.71116/8n3dc940
Samokhvalov, A. V., Zherdev, A. V., & Dzantiev, B. B. (2025) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683825601714
Tymecka, M., Skóra, M., Bonarek, P., Rajtar, N., & Kamiński, K. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115269
Dutta, D., Hoque, A. A., Paul, B., Park, J. H., Chowdhury, C., Quadir, M., Banerjee, S., Choudhury, A., Laha, S., Sepay, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26798754
Aptamers as immunomodulatory therapeutic alternatives targeting neglected tropical diseases (NTDs)
Silva, L. R., Silva, W. F. D. S., de Melo, A. C. F., Rodrigues, É. E. D. S., & da Silva-Júnior, E. F. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.02.010
Development of synthetic RNA using ultrahigh-throughput microfluidic screening
Husser, C. (2024) · theses.fr (ABES) · doi:10.70675/cc16e607z6679z4d14za678z981e7ce8fd8a
Modeling the dynamics and properties of key DNA lesions intermediates in realistic environments
Allahkaram, L. (2023) · theses.fr (ABES) · doi:10.70675/4585a058z6335z4b9az92a8zca19f33f93a3
Gangadaran, P., Kumar, A. S., Kumaran, K., Prakash, K., Dhayalan, S., Rajendran, R. L., Loganathbabu, V. K. T., Balaji, J., Baskaran, R., Arun, R., et al. (2026) · Cancers · doi:10.3390/cancers18081214
Relationship Between Financial Planning and Sustainable Growth in Ecuadorian Microenterprises
Rivera, D. P. I., Borja, C. G. B., Maiguashca, G. D. L. Á. G., & Quinatoa, G. J. A. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.22s.78
Gök, O., Uğurlu, Ö., Özyurt, C., & Evran, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094038
DNA aptamer based detection of thyroid stimulating hormone for point of care testing
Rosandi, R., Rudijanto, A., Aulanni'am, & Sujuti, H. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121059
Combinatorial and rational synthesis of complex, base-modified aptamer libraries on microarrays
Schaudy, E., & Lietard, J. (2026) · RSC Advances · doi:10.1039/d6ra01942k
Non-coding RNAs: Therapeutic Implications in Cancers
Alves, R., Jorge, J., Costa, M. I., Lapa, B., Sarmento‐Ribeiro, A. B., & Gonçalves, A. C. (2026) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-032-24071-2_10
Niu, M., Zou, Q., & Xu, L. (2026) · Bioinformatics Advances · doi:10.1093/bioadv/vbag168
Sa’adon, S. A., Rashid, N. N. A., Mustafa, K. M. F., Ong, E. B. B., Kin, W. W., & Othman, N. (2026) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2026.2690062
Branson, H., Khalique, A. A., Kronson, M. J., Carlin, D., Roof, A. E., Seto, M. K. C., David, Y., Cao, M., Barrett, S. E., Wu, T., et al. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00270
Fluorescent Metal Nanoclusters for Diagnostic and Therapeutic Applications
Zheng, J., Yuan, K., & Chen, S. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837679393-00348
Lee, M., Park, H., Kim, S., & Park, N. (2026) · Materials · doi:10.3390/ma19173707
Post-transcriptional regulation of erythropoiesis
Gnanapragasam, M. N., Sundaram, R. S. M., Adams, S. E., White, R. A., Dhara, A. R., Patel, P., Meem, S. M., & Ramamoorthy, M. (2026) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2026.06.006
Anticoagulant aptamers: from bench discovery to reversible clinical applications
Xia, X., Deng, Y., Li, Q., Bhattacharyya, S., Liu, Y., Huang, C. Z., Zuo, H., & Fang, L. (2026) · Science China Chemistry · doi:10.1007/s11426-026-3510-8
Wu, H.-B., Zeng, Z., Huang, W., Lin, X., Tian, R., Chen, J., & Zhang, Q.-L. (2026) · Biosensors · doi:10.3390/bios16100549
A tumor-targeting strategy based on covalent aptamer-carborane conjugates
Zhou, X., Jia, S., Xie, S., Qin, S., & Zhou, X. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110553
Sutar, P., Tripathi, D., & Maity, D. (2026) · Microchemical journal (Print) · doi:10.1016/j.microc.2026.119740
Effect of micro/nano-plastics on environment and recent advances in their detection strategies
Lourdes Jennifer, S., Manjuladevi, V., Panwar, J., & Verma, S. K. (2026) · Environmental Monitoring and Assessment · doi:10.1007/s10661-026-15995-7
Metadata
- Authors
- Adachi, T., & Nakamura, Y.
- Affiliations
- RIBOMIC Inc., Minato-ku, Tokyo 108-0071, Japan
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Adachi, Tatsuo
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-11-21
- Volume
- 24
- Issue
- 23
- Pages
- 4229
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6930564
- OpenAlex
- W2989998401
- Cited by
- 300
- References
- 115
- Citations by year
- 2026: 33 · 2025: 50 · 2024: 59 · 2023: 53 · 2022: 44 · 2021: 42 · 2020: 19
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Tokyo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- aptamers, aptamer therapeutics, chemical modification, oligonucleotide chemistry, pegaptanib, vascular endothelial growth factor, age-related macular degeneration, drug delivery
- MeSH terms
- Animals, Humans, Infections, Neoplasms, Aptamers, Nucleotide, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review